SFOSF.US Shanghai Fosun Pharmaceutical (Group) Co. Ltd

Healthcare Pharmaceuticals USA Stocks
14.59 USD
Close of Nov 17, 2026
1.88 2.72
Market cap
USD 8.05B
P/E
11.3x
P/B
0.76x
ROE
9.3%
Dividend yield
2.68%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SFOSF.US undervalued?

Graham number
Price14.59
Graham value23.68
Discount38.4%

SFOSF.US trades 38.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Fosun Pharmaceutical (Group) Co. Ltd fundamental analysis

No fundamental analysis for Shanghai Fosun Pharmaceutical (Group) Co. Ltd yet.

Shanghai Fosun Pharmaceutical (Group) Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Fosun Pharmaceutical (Group) Co. Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabo…

Full company profile